View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

The Metals Company Announces Second Quarter 2025 Corporate Update

The Metals Company Announces Second Quarter 2025 Corporate Update NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC”, the “Company” or “we”), a leading developer of the world’s largest estimated undeveloped resource of critical metals essential to energy, defense, manufacturing and infrastructure, today provided a corporate update and second quarter results for the period ending June 30, 2025. Q2 2025 Financial Highlights Total cash of approximately $115.8 million at June 30, 2025 $10.6 million cash used in operations for the quarter ended June ...

 PRESS RELEASE

Creative Realities Reports Fiscal 2025 Second Quarter Results

Creative Realities Reports Fiscal 2025 Second Quarter Results Revenue Growth Picks Up as Year Progresses; Company on Track for Record 2025 LOUISVILLE, Ky., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions, today announced its financial results for the fiscal second quarter ended June 30, 2025. Highlights: Second quarter revenue of $13.0 million versus $13.1 million in the prior-year periodGross profit of $5.0 million for th...

 PRESS RELEASE

Corvus Pharmaceuticals Provides Business Update and Reports Second Qua...

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2025 Financial Results Soquelitinib data from cohort 3 of atopic dermatitis Phase 1 clinical trial demonstrates earlier and deeper responses compared to cohorts 1-2 along with clinically meaningful reduction in itch as early as day 8 Enrollment ongoing in Phase 1 trial extension cohort 4 exploring the same cohort 3 dose (200 mg BID) for a longer 8-week treatment period; Phase 2 trial on track to initiate before end of year Phase 3 registrational clinical trial of soquelitinib in relapsed/refractory peripheral T ce...

 PRESS RELEASE

The Metals Company Announces Second Quarter 2025 Corporate Update Conf...

The Metals Company Announces Second Quarter 2025 Corporate Update Conference Call for Thursday, August 14, 2025  NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or the “Company”), a leading developer of the world’s largest estimated undeveloped resource of critical metals essential to energy, defense, manufacturing and infrastructure, today announced that it will host a conference call on Thursday, August 14, 2025, to provide an update on second quarter 2025 financial results and recent corporate developments.  Second Quarter 2025 Conference C...

 PRESS RELEASE

Creative Realities Deploys Digital Display Solution at Circle K Mexico...

Creative Realities Deploys Digital Display Solution at Circle K Mexico to Drive Sales and Advance Sustainability Efforts Pilot leverages localized digital signage to reduce environmental impact and enhance customer engagement, setting the stage for potential nationwide rollout MEXICO CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (NASDAQ: CREX), a leading provider of digital signage and media solutions, announced today the successful deployment of a proof-of-concept (PoC) digital signage system at Circle K Mexico. The initiative, launched at a select location, includes...

 PRESS RELEASE

TMC Releases Two Economic Studies with Combined NPV of $23.6B and Decl...

TMC Releases Two Economic Studies with Combined NPV of $23.6B and Declares World-First Nodule Reserves TMC published two technical economic assessments prepared in accordance with Subpart 1300 of Regulation S-K highlighting a total combined project value of $23.6 billion, showing potential economic viability of its NORI-D Project and significant scalability across other NORI and TOML areas World-first Pre-Feasibility Study (PFS) for a polymetallic nodule project in the NORI-D area with a Net Present Value (NPV) of $5.5 billion The PFS Technical Report Summary (TRS) marks a world-first decla...

 PRESS RELEASE

TMC and Tonga Announce Updated Sponsorship Agreement for Tonga Offshor...

TMC and Tonga Announce Updated Sponsorship Agreement for Tonga Offshore Mining Ltd (TOML) The Kingdom of Tonga and TMC’s subsidiary, Tonga Offshore Mining Ltd (TOML), signed a revised Sponsorship Agreement, updating the terms of their agreement signed in 2021The Government of the Kingdom of Tonga welcomes the new agreement which will ensure that Tongans will receive benefits from any future development of seafloor mineral resources by TOML or another TMC subsidiaryAs one of the first Developing States to apply for a marine mineral exploration contract, the Kingdom of Tonga has played a lead...

 PRESS RELEASE

Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2...

Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2025 Financial Results on August 7, 2025 Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT SOUTH SAN FRANCISCO, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on August 7, 2025 at 4:30 pm ET (1:30 pm PT) to provide a business update and report second quarter 2025 financial results.   The conference call can be accessed by dialing 1-800-717-173...

 PRESS RELEASE

Creative Realities, Inc. Announces Second Quarter 2025 Earnings Releas...

Creative Realities, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call Information LOUISVILLE, K.Y., July 30, 2025 (GLOBE NEWSWIRE) -- ("Creative Realities," "CRI," or the "Company") (NASDAQ: ), a leading provider of digital signage and media solutions, announced today that it will release its financial results for the three months ended June 30, 2025 before the market open on Wednesday, August 13, 2025. A conference call to review the results is scheduled for Wednesday, August 13, 2025, at 9:00 am Eastern Time, which will include prepared remarks and materials ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Receive...

Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis Trial will be conducted by Angel Pharma and will study 12-week dosing of soquelitinib in patients with moderate-to-severe atopic dermatitis SOUTH SAN FRANCISCO, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the IND application submitted by its partner in China, Angel Pharmaceuticals Ltd. (Angel Pharma), h...

 PRESS RELEASE

TMC Announces Appointment of Michael Hess and Alex Spiro to its Board ...

TMC Announces Appointment of Michael Hess and Alex Spiro to its Board of Directors Michael Hess, an experienced investor and operator in the energy sector, brings deep networks and expertise in financing and developing businesses focused on the U.S. energy supply chainAlex Spiro, a high-profile U.S. attorney and investor, joins with extensive regulatory, governance and capital markets experience across sectors including energy, technology, and miningAppointments strengthen TMC’s Board as the Company executes on its U.S. strategy and accelerates progress toward commercial recovery of polymet...

 PRESS RELEASE

TMC Announces Strategic Investment from Korea Zinc — a World-Leader in...

TMC Announces Strategic Investment from Korea Zinc — a World-Leader in Non-Ferrous Metal Refining and pCAM Technology — to Advance Development of Deep-Seabed Critical Minerals in the U.S. Korea Zinc Co., Ltd., (Korea Zinc) will make a strategic equity investment in TMC of $85.2 million in exchange for 19.6 million common shares at the last market closing price of $4.34 per shareInvestment includes a three-year warrant to purchase 6.9 million common shares (0.35 warrant shares for every 1 initial common share) with an exercise price of $7.00 per share, and a participation right to subscribe ...

 PRESS RELEASE

Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data Highligh...

Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data Highlighting Potential of ITK inhibition to Treat Systemic Sclerosis at EULAR 2025 Congress SOUTH SAN FRANCISCO, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced preclinical data highlighting the potential of soquelitinib to treat systemic sclerosis will be presented today in a poster session at the European Alliance of Associations for Rheumatology (EULAR) 2025 Congress, which is taking place June 11-14, 2025 in Barcelona. The pos...

 PRESS RELEASE

TMC and Nauru Announce Updated Sponsorship Agreement for Nauru Ocean R...

TMC and Nauru Announce Updated Sponsorship Agreement for Nauru Ocean Resources Inc. (NORI) The Government of Nauru and TMC’s subsidiary, Nauru Ocean Resources Inc. (NORI), signed a revised Sponsorship Agreement updating the terms of their agreement signed in 2017The President of Nauru welcomes the new agreement which will ensure that Nauruans will receive benefits from any future development of seafloor mineral resources from NORIThe Republic of Nauru has played a leading role in the development of the seafloor minerals industry, advancing the rights of Developing States to ensure their par...

 PRESS RELEASE

Corvus Pharmaceuticals Announces Full Data from Cohort 3 of Placebo-Co...

Corvus Pharmaceuticals Announces Full Data from Cohort 3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis Cohort 3 demonstrates earlier and deeper responses compared to cohorts 1-2 All three cohorts show separation from placebo with statistically significant difference from placebo at day 28 Cohort 3 demonstrates clinically meaningful reduction in itch as early as day 8 Enrollment initiated in extension cohort study exploring the same cohort 3 dose (200 mg BID) for a longer 8-week treatment period SOUTH SAN FRANCISCO, Calif., June 04, 2025 (GLOBE N...

 PRESS RELEASE

Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthc...

Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference SOUTH SAN FRANCISCO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one-on-one meetings with investors and present a corporate overview at the 2025 Jefferies Global Healthcare Conference, which is being held in New York, NY. The presentation will be on Thursday, June 5 from 9:20-9:50 am ET. A webcast of the presentation will be available live and for 90 days ...

 PRESS RELEASE

Creative Realities to Participate in Ladenburg Thalmann Innovation Exp...

Creative Realities to Participate in Ladenburg Thalmann Innovation Expo LOUISVILLE, Ky., May 15, 2025 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions, today announced that it will participate in the Ladenburg Thalmann Innovation Expo 2025, at Convene, 101 Park Avenue, New York on Wednesday May 21. One-on-one meetings will be available for institutional investors, and a general presentation will be held at 1pm Eastern. To schedule a meeting with CRI, contact Ladenb...

 PRESS RELEASE

TMC Provides First Quarter 2025 Corporate Update

TMC Provides First Quarter 2025 Corporate Update NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or “the Company”), a leading explorer of the world’s largest undeveloped resource of critical metals essential to energy, defense, manufacturing, and infrastructure, today provided a corporate update and first quarter results for the period ending March 31, 2025. Q1 2025 Financial Highlights Total liquidity of approximately $43.8 million at March 31, 2025, including cash of $2.3 million ERAS/Barron facility increased from $38 million to $44 million...

 PRESS RELEASE

Creative Realities Reports Fiscal 2025 First Quarter Results

Creative Realities Reports Fiscal 2025 First Quarter Results With New Wins on Hand, Company Remains Positioned for Record Year of Performance LOUISVILLE, Ky., May 14, 2025 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions, today announced its financial results for the fiscal first quarter ended March 31, 2025. Highlights: First quarter revenue of $9.7 million versus $12.3 million in the prior-year periodGross profit of $4.5 million for the three months ended Mar...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch